REBETOL Side Effects

6571230-8 | Cardiac Failure, Cardiomegaly, Face Oedema, Oedema Peripheral, Pleural Effusion
on Jan 22, 2010 Female patient from JAPAN , 65 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Rebetol (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure, cardiomegaly, face oedema, oedema peripheral, pleural effusion. Rebetol dosage: 600 Mg; Qd; Po. During the same period patient was treated with INTERFERON (6 Miu;qd; Indrip) (View Interferon Review and Interferon Label ), EVISTA (View Evista Review and Evista Label ).

6565880-2 | Congestive Cardiomyopathy
Patient was taking Rebetol (View Usage). Patient had the following side effects: congestive cardiomyopathy on Jan 18, 2010 from SPAIN Additional patient health information: Male patient , 48 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Rebetol dosage: 1200 Mg; Bid; Po. During the same period patient was treated with PEGASYS (180 Mg; Qw; Sc) (View Pegasys Review and Pegasys Label ). Patient was hospitalized.

6553514-2 | Bone Marrow Failure
Adverse event was reported on Jan 18, 2010 by a Female patient taking Rebetol (View Usage) (Dosage: For A Week.) was diagnosed with pneumonia parainfluenzae viral, prophylaxis against graft versus host disease and. Location: JAPAN , 42 years of age, After Rebetol was administered, patient had the following side effects: bone marrow failure. During the same period patient was treated with METHYLPREDNISOLONE (For 3 Days) (View Methylprednisolone Review and Methylprednisolone Label ), CYCLOPHOSPHAMIDE (Conditioning Regimen) (View Cyclophosphamide Review and Cyclophosphamide Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), METHOTREXATE (Short Term Methotrexate) (View Methotrexate Review and Methotrexate Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ).

6551340-1 | Loss Of Consciousness, Pulmonary Embolism
on Jan 12, 2010 Female patient from FRANCE , 76 years of age, was treated with Rebetol (View Usage). Patient experienced the following unwanted or unexpected effects: loss of consciousness, pulmonary embolism (What is pulmonary embolism?). Rebetol dosage: Po. During the same period patient was treated with PEGASYS (1 Df; Sc) (View Pegasys Review and Pegasys Label ), NEORECORMON (EPOETIN BETA) (1 Df; Once; Sc) (View Neorecormon (epoetin Beta) Review and Neorecormon (epoetin Beta) Label ). Patient was hospitalized.


6542928-2 | Cytolytic Hepatitis, Neutropenia
on Jan 08, 2010 Female patient from FRANCE , 48 years of age, was treated with Rebetol (View Usage). Patient had the following side effects: cytolytic hepatitis, neutropenia. Rebetol dosage: . During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ), SUBUTEX (View Subutex Review and Subutex Label ), LIPANTHYL (View Lipanthyl Review and Lipanthyl Label ), TIAPRIDAL (View Tiapridal Review and Tiapridal Label ), NOCTRAN (View Noctran Review and Noctran Label ), SERESTA (View Seresta Review and Seresta Label ), EFFEXOR (View Effexor Review and Effexor Label ), AST (View Ast Review and Ast Label ). Patient was hospitalized.

6537757-X | Anti-gad Antibody Positive, Diabetic Ketoacidosis, Type 1 Diabetes Mellitus
Patient was taking Rebetol (View Usage). After Rebetol was administered, patient had the following side effects: anti-gad antibody positive, diabetic ketoacidosis, type 1 diabetes mellitus on Jan 06, 2010 from JAPAN Additional patient health information: Male patient , 59 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Rebetol dosage: ; Po. During the same period patient was treated with PEG INTERFERON (PEGINTERFERON ALFA 2B) (View Peg-interferon (peginterferon Alfa-2b) Review and Peg-interferon (peginterferon Alfa-2b) Label ). Patient was hospitalized.

6526300-7 | Folate Deficiency, Hepatitis Cholestatic, Hepatocellular Injury, Idiopathic Thrombocytopenic Purpura
Adverse event was reported on Dec 16, 2009 by a Male patient taking Rebetol (View Usage) (Dosage: ; Po) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: FRANCE , 59 years of age, Patient experienced the following unwanted or unexpected effects: folate deficiency, hepatitis cholestatic, hepatocellular injury, idiopathic thrombocytopenic purpura. During the same period patient was treated with PEGASYS (; Iv) (View Pegasys Review and Pegasys Label ), AMANTADINE HCL (; Po) (View Amantadine Hcl Review and Amantadine Hcl Label ). Patient was hospitalized.

6507195-4 | Confusional State, Depression, Malaise, Oropharyngeal Blistering, Oropharyngeal Pain, Pharyngeal Oedema
on Dec 09, 2009 Female patient from UNITED STATES , 52 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Rebetol (View Usage). Patient had the following side effects: confusional state, depression (What is depression?), malaise, oropharyngeal blistering, oropharyngeal pain, pharyngeal oedema. Rebetol dosage: 800 Mg; Qd; Po; 200mg;qd;po. During the same period patient was treated with PEG INTRON (80 Mcg;qw; Sc) (View Peg-intron Review and Peg-intron Label ).

6490741-7 | Lymph Node Tuberculosis
on Dec 03, 2009 Male patient from JAPAN , 50 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Rebetol (View Usage). After Rebetol was administered, patient had the following side effects: lymph node tuberculosis. Rebetol dosage: . During the same period patient was treated with INTRON A (Dose: 1.5 Mu, Route: Injectable (not Otherwise Specified)) (View Intron A Review and Intron A Label ), TACROLIMUS HYDRATE (View Tacrolimus Hydrate Review and Tacrolimus Hydrate Label ), GRAN (Route: Injectable (not Otherwise Specified)) (View Gran Review and Gran Label ). Patient was hospitalized.

6457474-4 | Venous Thrombosis Limb
Patient was taking Rebetol (View Usage). Patient experienced the following unwanted or unexpected effects: venous thrombosis limb on Nov 12, 2009 from GERMANY Additional patient health information: Male patient , 63 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Rebetol dosage: . During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ). Patient was hospitalized.

6455997-5 | Anaemia Macrocytic, Marrow Hyperplasia
Adverse event was reported on Nov 13, 2009 by a Male patient taking Rebetol (View Usage) (Dosage: 1000 Mg;qd;po) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: FRANCE , 38 years of age, Patient had the following side effects: anaemia macrocytic, marrow hyperplasia. During the same period patient was treated with PEGASYS (180 Mcg;qw;sc) (View Pegasys Review and Pegasys Label ). Patient was hospitalized.

6448008-9 | Abdominal Distension, Bile Duct Cancer, Decreased Appetite
on Nov 05, 2009 Male patient from JAPAN , 58 years of age, was treated with Rebetol (View Usage). After Rebetol was administered, patient had the following side effects: abdominal distension, bile duct cancer, decreased appetite. Rebetol dosage: . During the same period patient was treated with PEG INTRON (View Peg-intron Review and Peg-intron Label ).

6428047-4 | Pulmonary Tuberculosis, Tuberculosis Of Intrathoracic Lymph Nodes
on Oct 26, 2009 Male patient from JAPAN , 50 years of age, was diagnosed with hepatitis chronic active and was treated with Rebetol (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary tuberculosis, tuberculosis of intrathoracic lymph nodes. Rebetol dosage: 200 Mg;qd;po, 400 Mg;qd;po. During the same period patient was treated with INTRON A (1.5 Miu;tiw;im, 3 Miu;tiw;im) (View Intron A Review and Intron A Label ), PROGRAF (View Prograf Review and Prograf Label ).

6427450-6 | Balance Disorder, Dehydration, Depression, Diarrhoea, Disturbance In Attention, Feeling Abnormal, Fluid Intake Reduced, Haematemesis, Headache
Patient was taking Rebetol (View Usage). Patient had the following side effects: balance disorder, dehydration, depression (What is depression?), diarrhoea, disturbance in attention, feeling abnormal, fluid intake reduced, haematemesis, headache (What is headache?) on Oct 25, 2009 from UNITED STATES Additional patient health information: Female patient , 40 years of age, weighting 135.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and. Rebetol dosage: Po. During the same period patient was treated with INTRON A (10 Miu;qd; 5 Miu;qd) (View Intron A Review and Intron A Label ), ZELNORM (View Zelnorm Review and Zelnorm Label ), ACIPHEX (View Aciphex Review and Aciphex Label ), LEXAPRO (View Lexapro Review and Lexapro Label ). Patient was hospitalized.

6411185-X | Lymph Node Tuberculosis, Pulmonary Tuberculosis
Adverse event was reported on Oct 13, 2009 by a Male patient taking Rebetol (View Usage) (Dosage: 200 Mg; Qd; Po, 400 Mg; Qd; Po) was diagnosed with hepatitis chronic active and. Location: JAPAN , 50 years of age, After Rebetol was administered, patient had the following side effects: lymph node tuberculosis, pulmonary tuberculosis. During the same period patient was treated with INTRON A (1.5 Miu; Tiw; Im, 3 Miu; Tiw; Im) (View Intron A Review and Intron A Label ).

6402287-2 | Hyperthyroidism
on Oct 08, 2009 Male patient from UNITED STATES , 38 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Rebetol (View Usage). Patient experienced the following unwanted or unexpected effects: hyperthyroidism. Rebetol dosage: 1200 Mg;qd. During the same period patient was treated with PEGASYS (Sc) (View Pegasys Review and Pegasys Label ).

6381562-4 | Lymphadenopathy
on Sep 21, 2009 Female patient from SPAIN , 47 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Rebetol (View Usage). Patient had the following side effects: lymphadenopathy. Rebetol dosage: 200 Mg; Po. During the same period patient was treated with PEGASYS (180 Mcg;qw;sc) (View Pegasys Review and Pegasys Label ).

6366385-4 | Alopecia, Bone Marrow Disorder, Depressed Mood, Face Oedema, Fatigue, Haemoglobin Decreased, Hyperthyroidism, Influenza Like Illness, Memory Impairment
Patient was taking Rebetol (View Usage). After Rebetol was administered, patient had the following side effects: alopecia, bone marrow disorder, depressed mood, face oedema, fatigue, haemoglobin decreased, hyperthyroidism, influenza like illness, memory impairment on Sep 03, 2009 from DENMARK Additional patient health information: Female patient , 38 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Rebetol dosage: 1000 Mg;qd;, 600 Mg;qd;. During the same period patient was treated with PEGASYS (80 Mcg;qd;, 135 Mcg;qw;) (View Pegasys Review and Pegasys Label ), GLUCOSAMIN /00943601/ (View Glucosamin /00943601/ Review and Glucosamin /00943601/ Label ), IRON (View Iron Review and Iron Label ), CALCIUM +VIT D (View Calcium +vit D Review and Calcium +vit D Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ).

6359330-9 | Acute Respiratory Distress Syndrome, Disseminated Intravascular Coagulation
Adverse event was reported on Sep 02, 2009 by a Female patient taking Rebetol (View Usage) (Dosage: ) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: JAPAN , 50 years of age, Patient experienced the following unwanted or unexpected effects: acute respiratory distress syndrome, disseminated intravascular coagulation. During the same period patient was treated with PEG INTRON (View Peg-intron Review and Peg-intron Label ).

6313840-9 | Anaemia, Apparent Life Threatening Event, Asterixis, Asthenia, Blood Creatinine Increased, Cardiac Disorder, Cerebral Atrophy, Cerebral Disorder, Cerebral Ischaemia
on Aug 12, 2009 Male patient from FRANCE , 56 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Rebetol (View Usage). Patient had the following side effects: anaemia, apparent life threatening event, asterixis, asthenia, blood creatinine increased, cardiac disorder, cerebral atrophy, cerebral disorder, cerebral ischaemia. Rebetol dosage: 600 Mg; Qw; Po; ;1200 Mg; Qw; Po; 200 Mg; Tiw; Po; 200 Mg; Biw; Po. During the same period patient was treated with PEGASYS (135 Mcg; Qw; Sc) (View Pegasys Review and Pegasys Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), TAREG (View Tareg Review and Tareg Label ), CELECTOL (View Celectol Review and Celectol Label ), CALTRATE (View Caltrate Review and Caltrate Label ). Patient was hospitalized.

6313818-5 | Hepatitis C, Renal Colic
on Aug 13, 2009 Female patient from FRANCE , 40 years of age, was diagnosed with hepatitis c (What is hepatitis c?), hiv infection (What is hiv infection?) and was treated with Rebetol (View Usage). After Rebetol was administered, patient had the following side effects: hepatitis c (What is hepatitis c?), renal colic. Rebetol dosage: 1000 Mg; Qd; Po. During the same period patient was treated with REYATAZ (400 Mg/kg; Qd; Po) (View Reyataz Review and Reyataz Label ). Patient was hospitalized.

6311683-3 | Endophthalmitis, Uveitis
Patient was taking Rebetol (View Usage). Patient experienced the following unwanted or unexpected effects: endophthalmitis, uveitis on Aug 05, 2009 from JAPAN Additional patient health information: Male patient , 73 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Rebetol dosage: . During the same period patient was treated with PEG INTRON (View Peg-intron Review and Peg-intron Label ). Patient was hospitalized.

6310659-X | Depression, Diabetes Mellitus, Pollakiuria
Adverse event was reported on Aug 05, 2009 by a Male patient taking Rebetol (View Usage) (Dosage: 1.2 Gm;qd) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: SWEDEN , 51 years of age, Patient had the following side effects: depression (What is depression?), diabetes mellitus, pollakiuria. During the same period patient was treated with PEGASYS (180 Mcg; Qw; Sc) (View Pegasys Review and Pegasys Label ). Patient was hospitalized.

6298871-X | Suicidal Ideation
on Aug 01, 2008 Female patient from UNITED STATES , 55 years of age, was treated with Rebetol (View Usage). After Rebetol was administered, patient had the following side effects: suicidal ideation. Rebetol dosage: .

6295135-5 | Interstitial Lung Disease
on Jul 24, 2009 Female patient from FRANCE , 65 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Rebetol (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease. Rebetol dosage: 600 Mg, Qd;.

6293514-3 | Lymphadenopathy
Patient was taking Rebetol (View Usage). Patient had the following side effects: lymphadenopathy on Jul 21, 2009 from SPAIN Additional patient health information: Female patient , 47 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Rebetol dosage: 200 Mg; ; Po. During the same period patient was treated with PEGASYS (180 Mg; Qw; Sc) (View Pegasys Review and Pegasys Label ).

6264270-X | Condition Aggravated, Cyanosis, Extremity Necrosis, Ischaemia, Oedema Peripheral, Raynaud's Phenomenon
Adverse event was reported on Jul 03, 2009 by a Male patient taking Rebetol (View Usage) (Dosage: ; Po) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: FRANCE , 47 years of age, After Rebetol was administered, patient had the following side effects: condition aggravated, cyanosis, extremity necrosis, ischaemia, oedema peripheral, raynaud's phenomenon. During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ). Patient was hospitalized.

6260483-1 | Hepatitis Acute
on Jun 29, 2009 Female patient from UNITED KINGDOM , 44 years of age, weighting 134.5 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Rebetol (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis acute. Rebetol dosage: 400 Mg; Bid; Po. During the same period patient was treated with PEGASYS (180 Mcg; Qw; Sc) (View Pegasys Review and Pegasys Label ). Patient was hospitalized.

6257761-9 | Acute Respiratory Distress Syndrome, Helicobacter Gastritis, Multi-organ Failure, Non-hodgkin's Lymphoma
on Jun 29, 2009 Male patient from FRANCE , 77 years of age, weighting 158.7 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Rebetol (View Usage). Patient had the following side effects: acute respiratory distress syndrome, helicobacter gastritis, multi-organ failure, non-hodgkin's lymphoma. Rebetol dosage: 800 Mg; Qd; Po. During the same period patient was treated with NEBIVOLOL (View Nebivolol Review and Nebivolol Label ), PRETERAX (View Preterax Review and Preterax Label ), TANAKAN (View Tanakan Review and Tanakan Label ), FORADIL (View Foradil Review and Foradil Label ), MIFLONIL (View Miflonil Review and Miflonil Label ), .. (View .. Review and .. Label ). Patient was hospitalized.

6253123-9 | Hyperglycaemia, Vision Blurred
Patient was taking Rebetol (View Usage). After Rebetol was administered, patient had the following side effects: hyperglycaemia, vision blurred on Jun 22, 2009 from UNITED STATES Additional patient health information: Male patient , 46 years of age, . Rebetol dosage: Po. During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), .. (View .. Review and .. Label ).

6212925-5 | Amnesia, Balance Disorder, Cerebral Atrophy, Cognitive Disorder, Dementia, Impaired Work Ability, Influenza, Muscle Spasms
Adverse event was reported on May 22, 2009 by a Male patient taking Rebetol (View Usage) (Dosage: Po) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: UNITED STATES , 47 years of age, Patient experienced the following unwanted or unexpected effects: amnesia, balance disorder, cerebral atrophy, cognitive disorder, dementia (What is dementia?), impaired work ability, influenza, muscle spasms. During the same period patient was treated with INTRON A (View Intron A Review and Intron A Label ).

6200981-X | Pulmonary Haemorrhage
on May 11, 2009 Female patient from JAPAN , 67 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Rebetol (View Usage). Patient had the following side effects: pulmonary haemorrhage. Rebetol dosage: . During the same period patient was treated with PEG INTRON (View Peg-intron Review and Peg-intron Label ).

6194962-2 | Anaemia, Asthenia, Dyspnoea, Leukopenia, Tachycardia
on May 07, 2009 Female patient from ITALY , 60 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Rebetol (View Usage). After Rebetol was administered, patient had the following side effects: anaemia, asthenia, dyspnoea, leukopenia, tachycardia. Rebetol dosage: 1000 Mg; Qd; Po. During the same period patient was treated with PEG INTRON (View Peg-intron Review and Peg-intron Label ), MICARDIS (TELMISARTAN+HYDROCHLOROTIAZIDE) (View Micardis (telmisartan+hydrochlorotiazide) Review and Micardis (telmisartan+hydrochlorotiazide) Label ).

6163342-8 | Skull Fracture, Subarachnoid Haemorrhage, Vertigo
Patient was taking Rebetol (View Usage). Patient experienced the following unwanted or unexpected effects: skull fracture, subarachnoid haemorrhage, vertigo on Apr 09, 2009 from ITALY Additional patient health information: Female patient , 71 years of age, was diagnosed with hepatitis chronic active, herpes simplex (What is herpes simplex?) and. Rebetol dosage: 800 Mgqd;po. During the same period patient was treated with PEGASYS (180 Mcg;qw; Sc) (View Pegasys Review and Pegasys Label ), FAMVIR (1000 Mg;qd;po) (View Famvir Review and Famvir Label ). Patient was hospitalized.

6159939-1 | Abdominal Pain, Anaemia, Diverticulum Intestinal, Hiatus Hernia, Nausea, Oesophagitis Ulcerative, Platelet Count Decreased, Reflux Oesophagitis
Adverse event was reported on Apr 09, 2009 by a Female patient taking Rebetol (View Usage) (Dosage: 200 Mg; Bid; Po) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: FRANCE , 65 years of age, Patient had the following side effects: abdominal pain (What is abdominal pain?), anaemia, diverticulum intestinal, hiatus hernia, nausea (What is nausea?), oesophagitis ulcerative, platelet count decreased, reflux oesophagitis. During the same period patient was treated with PEGASYS (CON.) (View Pegasys (con.) Review and Pegasys (con.) Label ). Patient was hospitalized.

6151835-9 | Dermatitis, Erythema Nodosum, Haemoglobin Decreased, Platelet Count Decreased, White Blood Cell Count Decreased
on Mar 30, 2009 Female patient from ITALY , 58 years of age, weighting 176.4 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Rebetol (View Usage). After Rebetol was administered, patient had the following side effects: dermatitis, erythema nodosum, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Rebetol dosage: 1000. During the same period patient was treated with PEGASYS (PEGINTERFERON ALFA 2B) (180) (180) (View Pegasys (peginterferon Alfa-2b) (180) Review and Pegasys (peginterferon Alfa-2b) (180) Label ).

6151828-1 | Anaemia, Diverticulum Intestinal, Gastrooesophageal Reflux Disease, Hiatus Hernia, Lymphocyte Count Increased, Neutrophil Count Increased, Oesophagitis Ulcerative, Platelet Count Decreased, White Blood Cell Count Decreased
on Apr 02, 2009 Female patient from FRANCE , 65 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Rebetol (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, diverticulum intestinal, gastrooesophageal reflux disease, hiatus hernia, lymphocyte count increased, neutrophil count increased, oesophagitis ulcerative, platelet count decreased, white blood cell count decreased. Rebetol dosage: 200 Mg;bid;po. During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ). Patient was hospitalized.

6151509-4 | Gingival Bleeding, Haemoglobin Decreased, Neutrophil Count Decreased, Platelet Count Decreased, White Blood Cell Count Decreased
Patient was taking Rebetol (View Usage). Patient had the following side effects: gingival bleeding, haemoglobin decreased, neutrophil count decreased, platelet count decreased, white blood cell count decreased on Mar 30, 2009 from ITALY Additional patient health information: Male patient , 44 years of age, weighting 207.2 lb, was diagnosed with hepatitis c (What is hepatitis c?) and. Rebetol dosage: . During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ). Patient was hospitalized.

6151503-3 | Asthenia, Syncope
Adverse event was reported on Mar 30, 2009 by a Male patient taking Rebetol (View Usage) (Dosage: ) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: ITALY , 61 years of age, weighting 163.1 lb, After Rebetol was administered, patient had the following side effects: asthenia, syncope. During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ).

6151495-7 | Jaundice
on Mar 30, 2009 Male patient from ITALY , 49 years of age, weighting 141.1 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Rebetol (View Usage). Patient experienced the following unwanted or unexpected effects: jaundice (What is jaundice?). Rebetol dosage: . During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ). Patient was hospitalized.

6151494-5 | Candidiasis, Gastrointestinal Haemorrhage, Haemolytic Anaemia, Oesophagitis, Portal Hypertensive Gastropathy
on Mar 30, 2009 Female patient from ITALY , 36 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Rebetol (View Usage). Patient had the following side effects: candidiasis, gastrointestinal haemorrhage, haemolytic anaemia, oesophagitis, portal hypertensive gastropathy. Rebetol dosage: . During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ). Patient was hospitalized.

6151485-4 | Angina Pectoris
Patient was taking Rebetol (View Usage). After Rebetol was administered, patient had the following side effects: angina pectoris on Mar 30, 2009 from ITALY Additional patient health information: Male patient , 68 years of age, weighting 165.3 lb, was diagnosed with hepatitis c (What is hepatitis c?) and. Rebetol dosage: . During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ).

6151315-0 | Anxiety, Syncope
Adverse event was reported on Mar 30, 2009 by a Female patient taking Rebetol (View Usage) (Dosage: 800 Mg;) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: ITALY , 42 years of age, weighting 130.1 lb, Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), syncope. During the same period patient was treated with PEGASYS (180 ;) (View Pegasys Review and Pegasys Label ).

6151293-4 | Asthenia, Dry Skin, Haemoglobin Decreased, Platelet Count Decreased, Pruritus, Skin Exfoliation, Weight Decreased
on Mar 30, 2009 Male patient from ITALY , 63 years of age, weighting 160.9 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Rebetol (View Usage). Patient had the following side effects: asthenia, dry skin, haemoglobin decreased, platelet count decreased, pruritus, skin exfoliation, weight decreased. Rebetol dosage: 1000. During the same period patient was treated with PEGASYS (180) (View Pegasys Review and Pegasys Label ).

6150183-0 | Dyspnoea, Pruritus, Urticaria
on Mar 30, 2009 Female patient from ITALY , 55 years of age, weighting 134.5 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Rebetol (View Usage). After Rebetol was administered, patient had the following side effects: dyspnoea, pruritus, urticaria. Rebetol dosage: 1000. During the same period patient was treated with PEGASYS (PEGINTERFERON ALFA 2A) (180 ) (180) (View Pegasys (peginterferon Alfa-2a) (180 ) Review and Pegasys (peginterferon Alfa-2a) (180 ) Label ).

6133545-7 | Skull Fractured Base, Subarachnoid Haemorrhage, Syncope
Patient was taking Rebetol (View Usage). Patient experienced the following unwanted or unexpected effects: skull fractured base, subarachnoid haemorrhage, syncope on Mar 16, 2009 from ITALY Additional patient health information: Female patient , 71 years of age, was diagnosed with hepatitis chronic active, herpes simplex (What is herpes simplex?) and. Rebetol dosage: 800 Mg;qd; Po. During the same period patient was treated with PEGASYS (180 Mcg;qw;sc) (View Pegasys Review and Pegasys Label ), FAMVIR (1000 Mg;qd;po) (View Famvir Review and Famvir Label ). Patient was hospitalized.

6124083-6 | Anaemia, Asthenia, Dyspnoea, Leukopenia, Tachycardia
Adverse event was reported on Mar 10, 2009 by a Female patient taking Rebetol (View Usage) (Dosage: 1000 Mg; Qd; Po) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: ITALY , 60 years of age, Patient had the following side effects: anaemia, asthenia, dyspnoea, leukopenia, tachycardia. During the same period patient was treated with PEG INTRON (View Peg-intron Review and Peg-intron Label ), MICARDIS (TELMISARTAN+HYDROCHLOROTHIAZIDE) (View Micardis (telmisartan+hydrochlorothiazide) Review and Micardis (telmisartan+hydrochlorothiazide) Label ).

6115924-7 | Head Injury, Skull Fracture, Subarachnoid Haemorrhage, Syncope
on Mar 03, 2009 Female patient from ITALY , 71 years of age, was diagnosed with hepatitis chronic active, herpes simplex (What is herpes simplex?) and was treated with Rebetol (View Usage). After Rebetol was administered, patient had the following side effects: head injury, skull fracture, subarachnoid haemorrhage, syncope. Rebetol dosage: 800 Mg; Qd; Po. During the same period patient was treated with PEGASYS (180 Mcg;qw; Sc) (View Pegasys Review and Pegasys Label ), FAMVIR (1000 Mg;qd;po) (View Famvir Review and Famvir Label ). Patient was hospitalized.

6112254-4 | Lymphoma
on Mar 06, 2009 Male patient from FRANCE , 75 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Rebetol (View Usage). Patient experienced the following unwanted or unexpected effects: lymphoma (What is lymphoma?). Rebetol dosage: Po.

6068379-5 | Anaemia, Confusional State, Convulsion, Depressed Level Of Consciousness, Haemoglobin Decreased, Lumbar Puncture Abnormal, Motor Dysfunction, Thrombotic Thrombocytopenic Purpura
Patient was taking Rebetol (View Usage). Patient had the following side effects: anaemia, confusional state, convulsion, depressed level of consciousness, haemoglobin decreased, lumbar puncture abnormal, motor dysfunction, thrombotic thrombocytopenic purpura on Jan 28, 2009 from FRANCE Additional patient health information: Female patient , 53 years of age, was diagnosed with hepatitis c (What is hepatitis c?), depression (What is depression?) and. Rebetol dosage: 800 Mg; Qd;po. During the same period patient was treated with PEGASYS (180 Mcg;qw;sc) (View Pegasys Review and Pegasys Label ), EFFEXOR (150 Mg;qd;po) (View Effexor Review and Effexor Label ), MANTADIX (View Mantadix Review and Mantadix Label ), ARANESP (View Aranesp Review and Aranesp Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ), CACIT VIT D3 (View Cacit Vit D3 Review and Cacit Vit D3 Label ), ACTONEL (View Actonel Review and Actonel Label ). Patient was hospitalized.